Los Angeles Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $413K | Sell |
6,588
-429,595
| -98% | -$34.4M | ﹤0.01% | 934 |
|
|
2025
Q4 | $43.9M | Buy |
436,183
+83,769
| +24% | +$8.21M | 0.15% | 110 |
|
|
2025
Q3 | $34.4M | Sell |
352,414
-291,906
| -45% | -$30.2M | 0.12% | 135 |
|
|
2025
Q2 | $69.2M | Buy |
644,320
+413,643
| +179% | +$41.9M | 0.26% | 81 |
|
|
2025
Q1 | $23.3M | Buy |
230,677
+219,201
| +1,910% | +$22.1M | 0.1% | 150 |
|
|
2024
Q4 | $1.03M | Sell |
11,476
-75,118
| -87% | -$6.61M | ﹤0.01% | 610 |
|
|
2024
Q3 | $7.26M | Sell |
86,594
-156,281
| -64% | -$12.3M | 0.03% | 279 |
|
|
2024
Q2 | $18.7M | Buy |
242,875
+54,138
| +29% | +$3.96M | 0.07% | 192 |
|
|
2024
Q1 | $12.9M | Buy |
188,737
+178,349
| +1,717% | +$11.5M | 0.04% | 258 |
|
|
2023
Q4 | $601K | Buy |
10,388
+113
| +1% | +$6.03K | ﹤0.01% | 817 |
|
|
2023
Q3 | $543K | Sell |
10,275
-82,919
| -89% | -$4.35M | ﹤0.01% | 799 |
|
|
2023
Q2 | $5.04M | Buy |
93,194
+80,781
| +651% | +$4.22M | 0.02% | 334 |
|
|
2023
Q1 | $621K | Sell |
12,413
-94,460
| -88% | -$4.45M | ﹤0.01% | 797 |
|
|
2022
Q4 | $4.95M | Buy |
106,873
+12,894
| +14% | +$558K | 0.02% | 379 |
|
|
2022
Q3 | $3.64M | Buy |
93,979
+38,360
| +69% | +$1.54M | 0.02% | 406 |
|
|
2022
Q2 | $2.07M | Sell |
55,619
-1,143
| -2% | -$46.5K | 0.01% | 528 |
|
|
2022
Q1 | $2.51M | Buy |
56,762
+8,134
| +17% | +$353K | 0.01% | 478 |
|
|
2021
Q4 | $2.07M | Sell |
48,628
-2,320
| -5% | -$97.5K | 0.01% | 510 |
|
|
2021
Q3 | $2.21M | Buy |
50,948
+7,033
| +16% | +$311K | 0.01% | 507 |
|
|
2021
Q2 | $1.88M | Sell |
43,915
-98,761
| -69% | -$4.15M | 0.01% | 599 |
|
|
2021
Q1 | $5.51M | Sell |
142,676
-113,414
| -44% | -$4.29M | 0.02% | 394 |
|
|
2020
Q4 | $9.21M | Buy |
256,090
+967
| +0.4% | +$34.9K | 0.04% | 298 |
|
|
2020
Q3 | $9.75M | Sell |
255,123
-451,742
| -64% | -$17.4M | 0.04% | 250 |
|
|
2020
Q2 | $24.8M | Buy |
706,865
+38,113
| +6% | +$1.37M | 0.12% | 172 |
|
|
2020
Q1 | $21.8M | Sell |
668,752
-616,839
| -48% | -$24.1M | 0.14% | 154 |
|
|
2019
Q4 | $58.1M | Sell |
1,285,591
-128,618
| -9% | -$5.38M | 0.29% | 91 |
|
|
2019
Q3 | $57.5M | Sell |
1,414,209
-580,934
| -29% | -$24.6M | 0.31% | 85 |
|
|
2019
Q2 | $85.8M | Sell |
1,995,143
-100,540
| -5% | -$3.87M | 0.46% | 55 |
|
|
2019
Q1 | $80.4M | Sell |
2,095,683
-78,537
| -4% | -$3M | 0.45% | 51 |
|
|
2018
Q4 | $76.8M | Sell |
2,174,220
-11,550
| -0.5% | -$419K | 0.48% | 50 |
|
|
2018
Q3 | $84.2M | Buy |
2,185,770
+201,430
| +10% | +$7.04M | 0.44% | 43 |
|
|
2018
Q2 | $64.9M | Buy |
1,984,340
+1,737
| +0.1% | +$52.4K | 0.36% | 49 |
|
|
2018
Q1 | $54.2M | Sell |
1,982,603
-3,025
| -0.2% | -$82.2K | 0.31% | 86 |
|
|
2017
Q4 | $49.2M | Sell |
1,985,628
-1,012,886
| -34% | -$27.9M | 0.27% | 91 |
|
|
2017
Q3 | $87.5M | Sell |
2,998,514
-43,950
| -1% | -$1.21M | 0.5% | 38 |
|
|
2017
Q2 | $84.3M | Buy |
3,042,464
+3,033,800
| +35,016% | +$80.5M | 0.53% | 34 |
|
|
2017
Q1 | $215K | Buy |
+8,664
| New | +$211K | ﹤0.01% | 1083 |
|
|
2016
Q4 | – | Sell |
-24,824
| Closed | -$591K | – | 1164 |
|
|
2016
Q3 | $591K | Sell |
24,824
-2,575
| -9% | -$61.4K | ﹤0.01% | 854 |
|
|
2016
Q2 | $640K | Sell |
27,399
-35,694
| -57% | -$772K | 0.01% | 835 |
|
|
2016
Q1 | $1.19M | Sell |
63,093
-3,672,743
| -98% | -$64.5M | 0.01% | 583 |
|
|
2015
Q4 | $68.9M | Sell |
3,735,836
-249,590
| -6% | -$4.47M | 0.63% | 34 |
|
|
2015
Q3 | $65.4M | Sell |
3,985,426
-68,350
| -2% | -$1.17M | 0.64% | 24 |
|
|
2015
Q2 | $71.8M | Sell |
4,053,776
-123,940
| -3% | -$2.21M | 0.67% | 18 |
|
|
2015
Q1 | $74.2M | Sell |
4,177,716
-1,227,258
| -23% | -$19.4M | 0.68% | 20 |
|
|
2014
Q4 | $71.6M | Buy |
5,404,974
+806,979
| +18% | +$10.3M | 0.66% | 35 |
|
|
2014
Q3 | $54.3M | Sell |
4,597,995
-1,806,674
| -28% | -$22.8M | 0.66% | 32 |
|
|
2014
Q2 | $81.8M | Sell |
6,404,669
-420,581
| -6% | -$5.47M | 0.79% | 19 |
|
|
2014
Q1 | $92.3M | Buy |
6,825,250
+2,487,830
| +57% | +$32.7M | 1.01% | 5 |
|
|
2013
Q4 | $52.1M | Sell |
4,337,420
-31,336
| -0.7% | -$370K | 0.58% | 30 |
|
|
2013
Q3 | $51.3M | Buy |
4,368,756
+854,259
| +24% | +$9.24M | 0.63% | 27 |
|
|
2013
Q2 | $32.6M | Buy |
+3,514,497
| New | +$29.8M | 0.46% | 44 |
|
Other funds holding BSX
VCM
VPM
Los Angeles Capital Management's BSX Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Boston Scientific (BSX) stake by 98% in Q1 2026, selling an estimated $34.4M and leaving 6,588 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #934.
Los Angeles Capital Management first reported a position in BSX in Q2 2013 and has held it in 51 quarters since. The position peaked at $92.3M in Q1 2014. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Los Angeles Capital Management held 6,588 shares of Boston Scientific worth $413K as of Q1 2026.
- Los Angeles Capital Management sold 429,595 Boston Scientific shares in Q1 2026, an estimated $34.4M.
- Boston Scientific made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #934 holding.
- Los Angeles Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 51 quarters since.
- Los Angeles Capital Management's Boston Scientific position peaked at $92.3M in Q1 2014.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.